Asia Pacific Geriatric Medicine Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$34,090.7

Forecast, 2030 (US$M)

$62,298.6

CAGR, 2024 - 2030

Report Coverage

Asia Pacific

Asia Pacific geriatric medicine market, 2018-2030 (US$M)

Related Markets

Global Geriatric Medicine Industry Outlook

North America Geriatric Medicine Market Outlook

Europe Geriatric Medicine Market Outlook

Latin America Geriatric Medicine Market Outlook

MEA Geriatric Medicine Market Outlook

Asia Pacific geriatric medicine market highlights

The Asia Pacific geriatric medicine market generated a revenue of USD 34,090.7 million in 2023.
The market is expected to grow at a CAGR of 9% from 2024 to 2030.
In terms of segment, analgesics was the largest revenue generating therapeutics in 2023.
Analgesics is the most lucrative therapeutics segment registering the fastest growth during the forecast period.

Asia Pacific data book summary

Market revenue in 2023	USD 34,090.7 million
Market revenue in 2030	USD 62,298.6 million
Growth rate	9% (CAGR from 2023 to 2030)
Largest segment	Analgesics
Fastest growing segment	Analgesics
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Analgesics

Other key industry trends

In terms of revenue, Asia Pacific region accounted for 21.6% of the global geriatric medicine market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 62,298.6 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Geriatric Medicine Market Scope

Geriatric medicine market segmentation & scope

Therapeutics

Analgesics

Antihypertensive

Statins

Antidiabetic

Proton Pump Inhibitors (PPI)

Anticoagulant

Antipsychotic

Other Therapeutics

Condition

Cardiovascular Diseases

Arthritis and Bone Health

Neurological Disorders

Cancer

Diabetes and Metabolic Disorders

Respiratory Diseases

Other Condition

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Mexico

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Japan

China

India

Australia

South Korea

Thailand

Brazil

Argentina

South Africa

Saudi Arabia

UAE

Kuwait

Geriatric Medicine Market Companies

Name	Profile	# Employees	HQ	Website

Asia Pacific geriatric medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to geriatric medicine market will help companies and investors design strategic landscapes.

Analgesics was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific geriatric medicine market based on analgesics covering the revenue growth of each sub-segment from 2018 to 2030.

Reasons to subscribe to Asia Pacific geriatric medicine market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific geriatric medicine market databook

Our clientele includes a mix of geriatric medicine market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific geriatric medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific geriatric medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list